-
hiPSC-Derived Intestinal Organoids Advance CYP2C19 Substrate
2026-07-09
This study establishes an efficient protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) to model human intestinal drug metabolism and absorption. The work demonstrates that these organoid-derived epithelial cells display key cytochrome P450 activities, offering a more predictive in vitro platform for pharmacokinetic research and CYP2C19 substrate evaluation.
-
Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl
2026-07-08
This study elucidates how Polo-like kinase 1 (Plk1) regulates the mitotic checkpoint by phosphorylating p31comet, thereby inhibiting its role in disassembling mitotic checkpoint complexes (MCCs). The findings clarify a key mechanism that prevents premature checkpoint inactivation, with implications for chromosome segregation fidelity and cancer research.
-
Cannabidiol Attenuates Orofacial Inflammatory Pain via CB1/C
2026-07-08
This study demonstrates that cannabidiol (CBD) robustly reduces both sensory and affective dimensions of orofacial inflammatory pain in mice, primarily through CB1 and CB2 receptor-mediated mechanisms. The findings highlight CBD's translational promise for comprehensive pain management and underscore the importance of multi-modal mechanistic approaches in pain research.
-
miR-18a/ALOXE3 Axis Drives Glioblastoma via Ferroptosis Supp
2026-07-07
This study reveals that miR-18a promotes glioblastoma progression by directly downregulating ALOXE3, which reduces ferroptotic cell death and enhances tumor cell migration. The findings highlight the miR-18a/ALOXE3 axis as a promising target for therapeutic intervention in glioblastoma and clarify the interplay between lipid metabolism and regulated cell death in this aggressive tumor type.
-
NSAIDs and Canine Osteosarcoma Cell Viability: Insights and
2026-07-07
This reference study evaluates the in vitro effects of deracoxib and piroxicam on the viability of canine osteosarcoma cells, focusing on their cytotoxic potential and underlying mechanisms. The findings highlight selective cytotoxicity at high concentrations, absence of apoptosis induction, and implications for translational oncology and bone metabolism research.
-
CGP 55845 Hydrochloride: Redefining GABAB Antagonist Researc
2026-07-06
Explore how CGP 55845 hydrochloride advances GABAB receptor antagonist studies by enabling precision dissection of astrocyte- and neuron-mediated neurotransmitter modulation. This article uniquely connects synaptic transmission research to practical assay optimization, grounded in recent glia-focused breakthroughs.
-
DiscoveryProbe Protease Inhibitor Library: Applied Workflows
2026-07-06
The DiscoveryProbe Protease Inhibitor Library empowers researchers with a validated, automation-ready solution for high throughput screening of protease function. Explore practical workflows, advanced use-cases, and troubleshooting strategies that leverage this library’s diversity and reproducibility in cancer, apoptosis, and infectious disease research.
-
Cimetidine: H2 Receptor Antagonist Distinctions for Research
2026-07-05
Cimetidine is a histamine-2 receptor antagonist with a unique partial agonist profile. Its validated purity and solubility properties make it a robust choice for mechanistic studies in gastrointestinal cancer and blood-brain barrier models. APExBIO provides Cimetidine (SKU B1557) for scientific research, facilitating reproducible results in advanced pharmacological workflows.
-
Scenario-Driven Solutions with (-)-Norepinephrine (+)-bitart
2026-07-04
This article provides actionable, evidence-based guidance for biomedical researchers and technicians using (-)-Norepinephrine (+)-bitartrate (SKU C8723) in cell viability, cardiovascular, and adrenergic signaling assays. Through real-world scenarios and literature-backed answers, it illustrates how APExBIO’s formulation supports experimental reliability and data integrity across challenging workflows.
-
Cell Integrity Sets Ploidy Limits in Budding Yeast
2026-07-03
This study demonstrates that the maximum ploidy in Saccharomyces cerevisiae is limited by the cell membrane’s ability to maintain integrity under increasing genomic content. By experimentally elevating ploidy and manipulating cell surface stress, the authors reveal a mechanistic link between genome duplication, cell size, and the regulation of membrane biosynthesis pathways, informing future research on polyploidy and antifungal strategies.
-
HyperScript First-Strand cDNA Synthesis Kit: Efficiency Unlo
2026-07-03
The HyperScript First-Strand cDNA Synthesis Kit enables high-fidelity cDNA synthesis from total RNA, even with complex secondary structures, by leveraging a thermostable, genetically engineered reverse transcriptase. APExBIO’s kit supports robust PCR amplification and qPCR workflows, and demonstrates superior performance for low-abundance transcripts.
-
JNK-IN-7: Selective JNK Inhibitor Empowering Apoptosis Assay
2026-07-02
JNK-IN-7 is a highly selective JNK inhibitor that enables precise dissection of MAPK and innate immune signaling in cell-based assays. This article translates recent findings in BMEC apoptosis into actionable protocols, troubleshooting tips, and comparative advantages for researchers studying inflammation and cell death pathways.
-
CKI 7 dihydrochloride: Reliable Casein Kinase 1 Inhibitor Wo
2026-07-02
This article dissects common laboratory challenges in cell signaling and viability assays, showing how CKI 7 dihydrochloride (SKU B4936) from APExBIO offers robust, evidence-backed solutions. Scenario-driven Q&A blocks, grounded in recent literature and product specification, guide researchers toward reproducible, efficient, and interpretable Casein kinase 1 inhibition workflows.
-
Sulfo-NHS-SS-Biotin: Precision Protein Labeling for Affinity
2026-07-01
Sulfo-NHS-SS-Biotin’s water solubility and cleavable disulfide bond enable selective, reversible protein labeling—ideal for surface proteomics and advanced purification workflows. APExBIO's reagent eliminates organic solvents, streamlining membrane-impermeant biotinylation with maximal specificity and minimal background.
-
Mitomycin C in Cancer Immunology: Bridging DNA Damage and Im
2026-07-01
Explore the dual role of Mitomycin C as an antitumor antibiotic in DNA replication inhibition and immune modulation. This article uniquely examines how integrating apoptosis signaling research with modern immunotherapy design advances cancer research.